Terms: = Pancreatic cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Prognosis
25 results:
1. What is an "early palliative care" intervention? A scoping review of controlled studies in oncology.
Nadolny S; Schildmann E; Gaßmann ES; Schildmann J
Cancer Med; 2023 Dec; 12(23):21335-21353. PubMed ID: 37902232
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic differences in grading and metastatic lymph node pattern in patients with small bowel neuroendocrine tumors.
Reinhard L; Mogl MT; Benz F; Dukaczewska A; Butz F; Dobrindt EM; Tacke F; Pratschke J; Goretzki PE; Jann H
Langenbecks Arch Surg; 2023 Jun; 408(1):237. PubMed ID: 37332044
[TBL] [Abstract] [Full Text] [Related]
3. The Impact of Sarcopenia Onset Prior to cancer Diagnosis on cancer Survival: A National Population-Based Cohort Study Using Propensity Score Matching.
Su CH; Chen WM; Chen MC; Shia BC; Wu SY
Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904245
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic impact of conversion hepatectomy for initially unresectable colorectal liver metastasis.
Takamizawa Y; Inoue M; Moritani K; Tsukamoto S; Esaki M; Shimada K; Kanemitsu Y
Langenbecks Arch Surg; 2022 Nov; 407(7):2893-2903. PubMed ID: 36068379
[TBL] [Abstract] [Full Text] [Related]
5. Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms?
Borbon LC; Tran CG; Sherman SK; Ear PH; Chandrasekharan C; Bellizzi AM; Dillon JS; O'Dorisio TM; Howe JR
Ann Surg Oncol; 2022 Oct; 29(11):6936-6946. PubMed ID: 35802214
[TBL] [Abstract] [Full Text] [Related]
6. SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine.
Wang ZW; Pan JJ; Hu JF; Zhang JQ; Huang L; Huang Y; Liao CY; Yang C; Chen ZW; Wang YD; Shen BY; Tian YF; Chen S
Cell Rep; 2022 May; 39(6):110813. PubMed ID: 35545048
[TBL] [Abstract] [Full Text] [Related]
7. Inflammatory cytokine-regulated tRNA-derived fragment tRF-21 suppresses pancreatic ductal adenocarcinoma progression.
Pan L; Huang X; Liu ZX; Ye Y; Li R; Zhang J; Wu G; Bai R; Zhuang L; Wei L; Li M; Zheng Y; Su J; Deng J; Deng S; Zeng L; Zhang S; Wu C; Che X; Wang C; Chen R; Lin D; Zheng J
J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34779408
[TBL] [Abstract] [Full Text] [Related]
8. ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis.
Islam S; Kitagawa T; Baron B; Abiko Y; Chiba I; Kuramitsu Y
Sci Rep; 2021 May; 11(1):10563. PubMed ID: 34007003
[TBL] [Abstract] [Full Text] [Related]
9. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis.
Guo X; Zhou Q; Su D; Luo Y; Fu Z; Huang L; Li Z; Jiang D; Kong Y; Li Z; Chen R; Chen C
Mol Cancer; 2020 May; 19(1):83. PubMed ID: 32375768
[TBL] [Abstract] [Full Text] [Related]
10. Identification of novel mRNA-miRNA-lncRNA competing endogenous RNA network associated with prognosis of breast cancer.
Zhong G; Lou W; Yao M; Du C; Wei H; Fu P
Epigenomics; 2019 Oct; 11(13):1501-1518. PubMed ID: 31502865
[No Abstract] [Full Text] [Related]
11. [Clinicopathological features and prognosis of 488 patients with neuroendocrine tumors].
Zhai XJ; Yu SL; Ma YH; Wang F; Yang MJ; Lian YJ; Yu XX; Fan QX; Song LJ
Zhonghua Yi Xue Za Zhi; 2019 Aug; 99(32):2527-2531. PubMed ID: 31484281
[No Abstract] [Full Text] [Related]
12. High stromal transforming growth factor β-induced expression is a novel marker of progression and poor prognosis in gastric cancer.
Suzuki M; Yokobori T; Gombodorj N; Yashiro M; Turtoi A; Handa T; Ogata K; Oyama T; Shirabe K; Kuwano H
J Surg Oncol; 2018 Nov; 118(6):966-974. PubMed ID: 30260476
[TBL] [Abstract] [Full Text] [Related]
13. [Impact of previous abdominal surgery on the outcomes of laparoscopic resection for colorectal cancer].
Tao J; Wang X; Liu Z; Jiang Z; Guo C; Chen J; Wang Z; Liu Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Mar; 21(3):292-298. PubMed ID: 29577217
[TBL] [Abstract] [Full Text] [Related]
14. The Significance of the Prognostic Nutritional Index for All Stages of pancreatic cancer.
Lee SH; Chung MJ; Kim B; Lee HS; Lee HJ; Heo JY; Kim YJ; Park JY; Bang S; Park SW; Song SY; Chung JB
Nutr Cancer; 2017 Apr; 69(3):512-519. PubMed ID: 27967240
[TBL] [Abstract] [Full Text] [Related]
15. Expression Patterns of Growth and Survival Genes with Prognostic Implications in Advanced pancreatic cancer.
Pectasides D; Kotoula V; Papaxoinis G; Alexopoulou Z; Dervenis C; Samantas E; Papaparaskeva K; Charalambous E; Gkakou C; Agalianos C; Kalogeras KT; Pentheroudakis G; Fountzilas G
Anticancer Res; 2016 Dec; 36(12):6347-6356. PubMed ID: 27919956
[TBL] [Abstract] [Full Text] [Related]
16. The detail of the en bloc technique and prognosis of spleen-preserving laparoscopic distal pancreatectomy for pancreatic cancer.
Sun Z; Zhu Y; Zhang N
World J Surg Oncol; 2015 Nov; 13():322. PubMed ID: 26607990
[TBL] [Abstract] [Full Text] [Related]
17. MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting akt2.
Sun Y; Zhang T; Wang C; Jin X; Jia C; Yu S; Chen J
PLoS One; 2015; 10(4):e0119783. PubMed ID: 25856297
[TBL] [Abstract] [Full Text] [Related]
18. Pharmacogenomics update in pancreatic cancer.
Puri A; Saif MW
JOP; 2014 Mar; 15(2):114-7. PubMed ID: 24618431
[TBL] [Abstract] [Full Text] [Related]
19. Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior.
Morin E; Cheng S; Mete O; Serra S; Araujo PB; Temple S; Cleary S; Gallinger S; Greig PD; McGilvray I; Wei A; Asa SL; Ezzat S
Cancer Med; 2013 Oct; 2(5):701-11. PubMed ID: 24403235
[TBL] [Abstract] [Full Text] [Related]
20. Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer.
Sugiura T; Uesaka K; Mihara K; Sasaki K; Kanemoto H; Mizuno T; Okamura Y
Surgery; 2013 Nov; 154(5):1078-86. PubMed ID: 23973112
[TBL] [Abstract] [Full Text] [Related]
[Next]
